Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,170.00
Bid: 12,172.00
Ask: 12,174.00
Change: 108.00 (0.90%)
Spread: 2.00 (0.016%)
Open: 12,194.00
High: 12,266.00
Low: 12,054.00
Prev. Close: 12,062.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: FTSE 100 Slides On US Jobs Data, Miners Weigh

Fri, 06th Mar 2015 16:51

LONDON (Alliance News) - The FTSE 100 ended lower Friday, and ended down over the week as a whole, as London-listed mining stocks were again hit by lower commodity prices, and as stocks in the US were hit by a by a better-than-expected US jobs report that raised expectations the Federal Reserve could start raising interest rates as soon as June.

The FTSE 100 was lower from the start as mining stocks came under pressure from lower commodity prices. The index has a large number of constituents in the sector. It dropped further once the US jobs data was released.

The blue-chip index closed down 0.7% at 6,911.80, meaning it was down 0.5% for the week as a whole. The FTSE 250 closed down 0.2% at 17,272.21, while the AIM All-Share index outperformed, closing up 0.6% at 718.11.

The US Labor Department said non-farm payroll employment jumped by 295,000 jobs in February, following a downwardly revised increase of 239,000 jobs in January. Economists had expected employment to increase by about 230,000 jobs compared with the addition of 257,000 jobs originally reported for the previous month.

The US unemployment rate fell to 5.5% in February, from 5.7% in January, coming in below economists' estimates for a rate of 5.6% and recording its lowest level since hitting 5.4% in May of 2008.

"I think this is a very good labour market report and will only feed into expectations for a rate hike from the Federal Reserve in June," said Oanda analyst Craig Erlam.

But Erlam thinks the June meeting may just come a little soon, with wage growth not quite taking off yet. "I still believe that the Fed will wait until September to act. They are clearly in no rush to make this decision and with inflation below target, they don’t need to," he said.

The dollar strengthened further against its major counterparts in the wake of the report, trading the pound at USD1.5081 while the euro was at its lowest level since September 2003 at USD1.0876.

The gold price fell due to the dollar's rise, and was quoted at USD1,174.02 when the London equity markets closed, its lowest level since early January.

When the London equity markets closed, Wall Street was lower, with the DJIA down 1.0%, the S&P 500 down 0.8% and the Nasdaq Composite down 0.6%. Tech giant Apple will replace AT&T in the DJIA on March 18.

In Europe, the CAC 40 in Paris closed up 0.1%, and the DAX 30 in Frankfurt ended up 0.4%.

Fourth quarter eurozone GDP met expectations, rising 0.9% quarter-on-quarter. The figure was a slight improvement on the third quarter reading of 0.8%. The year-on-year figure also matched estimates of 0.3% growth, marginally higher than the 0.2% shown in the third quarter.

The median expectations for UK inflation for the coming year was 1.9% in February compared with 2.5% in November, according to a survey from the Bank of England. This was its lowest level in more than 13 years. UK inflation had fallen to a record low 0.3% in January, dragged by falling motor fuel and food prices.

In London, gold miners suffered from the weakness of the precious metal price, with Randgold Resources ending as the worst performer in the FTSE 100, down 5.3%, followed by Fresnillo, down 5.2%.

Anglo American was down 2.5% while Rio Tinto slid 2.3% as iron ore prices fell to a fresh six-year low, according to reports.

Outside of mining, AstraZeneca closed down 1.6%. The pharmaceutical giant guided that it expects its total revenue to decline by a mid-single digit percentage at constant exchange rates in 2015, in line with previous sales revenue guidance it gave at the time of its full-year results, as it announced changes to the way it presents its revenue. AstraZeneca maintained its core earnings per share guidance.

Oil and gas service company Weir Group was the biggest gainer in the blue-chip index, up 4.3% at 1,827 pence, as several media reported speculation that it could attract a bid from a US private equity firm. The Independent said that GE Capital is being linked with making a 2,800.00 pence per share bid, though it attributed this to "starry-eyed punters".

Shares in FTSE 250-listed Thomas Cook Group flew up 25%, after Chinese investment firm Fosun International bought a 5% stake in the UK travel operator and said it plans to increase its stake to 10% by buying shares in the open market over time.

Under the deal, Thomas Cook will issue Fosun with 73.1 million new shares for GBP91.8 million, giving it a 5% stake in the business. Fosun will then buy shares in the open market to take its stake up to about 10% over time. The share issue values Thomas Cook shares at 125.58 pence.

In the corporate calendar Monday, WPP, Clarkson, HgCapital Trust, Hansteen Holdings and Mincon Group will issue full year results, while Gemfields and Abcam will release half year results.

In the economic calendar, German current account and import and export data are due at 0700 GMT. Eurozone sentix investor confidence is at 0930 GMT followed by the Eurogroup meeting in Brussels at 1530 GMT. In the US, Labor market conditions index is at 1400 GMT.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.